In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus

M. Venditti, Brunella Posteraro, G. Morace, P. Martino

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Abstract

Blastoschizomyces capitatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eight-fold more active than amphotericin B and ketoconazole against all isolates but one.
Original languageEnglish
Pages (from-to)13-15
Number of pages3
JournalJournal of Chemotherapy
Volume3
DOIs
Publication statusPublished - 1991

Keywords

  • Antifungal Agents
  • Fluconazole
  • Geotrichum
  • Microbial Sensitivity Tests
  • Mitosporic Fungi
  • Trichosporon

Fingerprint

Dive into the research topics of 'In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus'. Together they form a unique fingerprint.

Cite this